Citadel Advisors’s EQ Health Acquisition Corp. EQHA Stock Holding History

Citadel Advisors’s Portfolio EQHA Stock Details EQHA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-461,154	Closed	-$4.55M	–	15832
2022 Q3	$4.55M	Sell	461,154 -932	-0.2%	-$9.18K	﹤0.01%	4033
2022 Q2	$4.54M	Sell	462,086 -268	-0.1%	-$2.63K	﹤0.01%	3984
2022 Q1	$4.53M	Buy	462,354 +108	+0%	+$1.05K	﹤0.01%	4370
2021 Q4	$4.49M	Sell	462,246 -124	-0%	-$1.21K	﹤0.01%	4511
2021 Q3	$4.52M	Buy	462,370 +341,926	+284%	+$3.31M	﹤0.01%	4504
2021 Q2	$1.16M	Buy	120,444 +58	+0%	+$566	﹤0.01%	7960
2021 Q1	$1.17M	Buy	+120,386	New	+$1.17M	﹤0.01%	7724

Other funds holding EQHA

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Citadel Advisors's EQHA Position: Q4 2022 in Review

Citadel Advisors sold out of EQ Health Acquisition Corp. (EQHA) in Q4 2022, closing a stake of 461,154 shares — an estimated $4.55M sold.

Citadel Advisors first reported a position in EQHA in Q1 2021 and held it in 7 quarters. The position peaked at $4.55M in Q3 2022. 4 funds tracked by Wall St. Rank hold EQHA as of Q4 2022.

Citadel Advisors reported no remaining EQ Health Acquisition Corp. position as of Q4 2022 after selling out during the quarter.
Citadel Advisors sold 461,154 EQ Health Acquisition Corp. shares in Q4 2022, an estimated $4.55M.
Citadel Advisors first reported a position in EQ Health Acquisition Corp. in Q1 2021 and held it in 7 quarters.
Citadel Advisors's EQ Health Acquisition Corp. position peaked at $4.55M in Q3 2022.
4 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.